In summary, the antifungal armamentarium has exploded in the past few years, and more options are available to clinicians treating patients with these challenging problems. As in all immunocompromised hosts, success depends a great deal on repairing the defect within the host immune system. These drugs hopefully give us that window of opportunity.
|Number of pages||2|
|Journal||Journal of Supportive Oncology|
|State||Published - Jul 2005|